Publications

December 18, 2018

Cost-effectiveness PCT guided therapy in reduction AB resistance

Antibiotic (AB) resistance and Clostridium difficile infections (CDI) have become an increasing problem when AB is overused or wrongfully prescribed. […]
April 19, 2018

Enabling equal access to molecular diagnostics: what are the implications for policy and Health Technology Assessment?

2016 Plun et al Enabling equal access to molecular diagnostics – what are the implications for policy and Health Technology […]
April 19, 2017

IT as the cornerstone for precision medicine and scientific wellness

At the 11th Precision Medicine World Conference in Silicon Valley (22-25 Jan), a plethora of precision medicine technologies, many of […]
July 6, 2016

Economic impact of integrated care models for patients with chronic diseases

A study into the economic impact of Integraded Care Models was published in Value of Health. The study focused on […]
June 17, 2016

Management and performance features of cancer centers in Europe

Isabelle is a co-author on a paper in which the performance features of cancer centers in the European Union are […]
June 13, 2016

New VOKA white paper: Value based care innovation and logistics

Panaxea contributed to the new Voka white paper: Value based care innovation and logistics. This white paper shares the vision of […]
June 8, 2016

Implications for policy and Health Technology Assessment when enabling equal access to molecular diagnostics

Lotte Steuten is co-author on a new paper regarding Molecular Diagnostics, published by Public Health Genomics. The paper, with Juliette […]
March 31, 2016

Gimon de Graaf and Lotte Steuten co-authors on web-based tool paper

Gimon De Graaf and Lotte Steuten are co-authors on paper about the development of a web-based tool for the assessment […]
May 19, 2015

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the Netherlands

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the […]
April 20, 2015

Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective

Michelle Kip, Helma Monteban & Lotte Steuten, Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost […]